Risk of preterm delivery and small-for-gestational-age births in women with autoimmune disease using biologics before or during pregnancy: a population-based cohort study

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Annals of the Rheumatic Diseases

• Publication date

  2018-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/annrheumdis-2018-213023PMID 29496718
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Patterns of Biologics Utilization and Discontinuation Before and During Pregnancy in Women With Autoimmune Diseases: A Population‐Based Cohort Study

  2018cited by this paper
• Psoriasis pathogenesis and the development of novel targeted immune therapies

  2017cited by this paper
• Immunomodulation of autoimmune arthritis by pro-inflammatory cytokines.

  2017cited by this paper
• Interleukins (from IL-1 to IL-38), interferons, transforming growth factor β, and TNF-α: Receptors, functions, and roles in diseases.

  2016cited by this paper
• Adalimumab long-term safety: infections, vaccination response and pregnancy outcomes in patients with rheumatoid arthritis

  2016cited by this paper
• CDC Grand Rounds: Public Health Strategies to Prevent Preterm Birth.

  2016cited by this paper
• Autoimmune connective tissue diseases.

  2015cited by this paper
• OP0017 Pregnancies in Patients with Rheumatoid Arthritis: Treatment Decisions, Course of the Disease, and Pregnancy Outcomes

  2015cited by this paper
• Pregnancy outcome following gestational exposure to TNF-alpha-inhibitors: a prospective, comparative, observational study.

  2014cited by this paper
• FRI0090 Pregnancy Outcome of Mothers with Rheumatic Diseases Exposed to Biological Agent during Pregnancy: A Single-Centre Study

  2014cited by this paper
• Inflammatory bowel disease: pathogenesis.

  2014cited by this paper
• Factors associated with pregnancy outcome in anti‐TNF treated women with inflammatory bowel disease

  2014cited by this paper
• Interaction of pregnancy and autoimmune rheumatic disease.

  2012cited by this paper
• Anti-TNF therapies and pregnancy: outcome of 130 pregnancies in the British Society for Rheumatology Biologics Register

  2011cited by this paper
• Outcome of pregnancy in women with inflammatory bowel disease treated with antitumor necrosis factor therapy

  2011cited by this paper
• Fetal Growth: Measurement and Evaluation

  2011cited by this paper
• Reproductive and Perinatal Epidemiology

  2011cited by this paper
• Crohn's disease is a risk factor for preterm birth.

  2010cited by this paper
• High-dimensional Propensity Score Adjustment in Studies of Treatment Effects Using Health Care Claims Data

  2009cited by this paper
• Cytokines in the pathogenesis of rheumatoid arthritis

  2007cited by this paper
• Variable selection for propensity score models.

  2006cited by this paper
• New birth weight and gestational age charts for the British Columbia population

  2006cited by this paper
• Tumor necrosis factor receptor 1 expression and early spontaneous abortion

  2005cited by this paper
• Maternal serum levels of interferon‐γ and interleukin‐2 soluble receptor‐α predict the outcome of early IVF pregnancies

  2004cited by this paper
• Maternal serum levels of interferon-gamma and interleukin-2 soluble receptor-alpha predict the outcome of early IVF pregnancies.

  2004cited by this paper
• Maternal serum interleukin-6, interleukin-8, tumor necrosis factor-alpha and interferon-gamma in preterm labor.

  2003cited by this paper
• Maternal serum interleukin‐6, interleukin‐8, tumor necrosis factor‐α and interferon‐γ in preterm labor

  2003cited by this paper
• Tumor necrosis factor during pregnancy and at the onset of labor and spontaneous abortion.

  1999cited by this paper
• Tumour necrosis factor-alpha induces cyclo-oxygenase-2 gene expression in first trimester trophoblasts: suppression by glucocorticoids and NSAIDs.

  1997cited by this paper
• Spurious effects from an extraneous variable.

  1966cited by this paper
• Extended Report

  year unknowncited by this paper

• Perinatal use of targeted synthetic DMARDs and maternal-neonatal outcomes in autoimmune disease: A population-based cohort study.

  2026cites this paper
• Genetically proxied tumour necrosis factor inhibition and pregnancy-related maternal and foetal outcomes in the general population: a Mendelian randomization study

  2025cites this paper
• Use of Biologics During Pregnancy Among Patients With Autoimmune Conditions

  2025cites this paper
• The outcomes of children born to mothers with autoimmune rheumatic diseases.

  2024cites this paper
• In Utero Exposure to Antibiotics and Risk of Serious Infections in the First Year of Life

  2024cites this paper
• Prenatal Exposure to Proton Pump Inhibitors and Risk of Serious Infections in Offspring During the First Year of Life: A Nationwide Cohort Study

  2024cites this paper
• Treatment of spondyloarthritis with disease-modifying anti-rheumatic drugs during pregnancy and breastfeeding: comparing the recommendations and guidelines of the principal societies of rheumatology.

  2024cites this paper
• Drug-induced fetal and offspring disorders, beyond birth defects.

  2023cites this paper
• British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: immunomodulatory anti-rheumatic drugs and corticosteroids

  2022cites this paper
• Risk of preterm delivery and small for gestational age among women with inflammatory bowel disease using TNF-alpha inhibitors during pregnancy.

  2022cites this paper
• Rheumatoid arthritis and the risk of preterm birth

  2022cites this paper
• Stopping bDMARDs at the beginning of pregnancy is associated with disease flares and preterm delivery in women with rheumatoid arthritis

  2022cites this paper
• Oncology

  2021cites this paper
• Recent insights into the impact of immune dysfunction on reproduction in autoimmune thyroiditis.

  2021cites this paper
• Pregnancy and neonatal outcomes in women with immune mediated inflammatory diseases exposed to anti-tumor necrosis factor-α during pregnancy: A systemic review and meta-analysis.

  2021cites this paper
• The use and impact of monoclonal antibody biologics during pregnancy

  2021cites this paper
• Aktuelles zur antirheumatischen Therapie bei Kinderwunsch, Schwangerschaft und Stillzeit

  2021cites this paper
• Utilisation et incidence des agents biologiques à base d’anticorps monoclonaux durant la grossesse

  2021cites this paper
• Fetal and maternal outcomes after maternal biologic use during conception and pregnancy: A systematic review and meta‐analysis

  2021cites this paper
• Anti‐TNF treatment during pregnancy and birth outcomes: A population‐based study from Denmark, Finland, and Sweden

  2020cites this paper
• Pregnancy outcomes and perinatal complications of Asian mothers with juvenile idiopathic arthritis – a case-control registry study

  2020cites this paper
• The exposure to biologic and targeted synthetic disease-modifying antirheumatic drugs in pregnancy and lactation

  2020cites this paper
• Intrauterine Exposure to Biologics in Inflammatory Autoimmune Diseases: A Systematic Review

  2020cites this paper
• Artritis Reumatoide y embarazo. Actualización

  2020cites this paper
• Introduction to High-dimensional Propensity Score Analysis

  2020cites this paper
• Gebelikte Sık Karşılaşılan Otoimmün Hastalıklar ve Ebelik Yaklaşımı

  2020influential citation
• Maternal and neonatal outcomes associated with biologic exposure before and during pregnancy in women with inflammatory systemic diseases: a systematic review and meta-analysis of observational studies.

  2020cites this paper
• Peripartum issues in the inflammatory arthritis patient: A survey of the RAPPORT registry

  2020cites this paper
• Pregnancy outcomes in DMARD-exposed patients with juvenile idiopathic arthritis-results from a JIA biologic registry.

  2019cites this paper
• Evaluation of the Developmental Toxicity of Vedolizumab, an α4β7 Receptor Antagonist, in Rabbit and Nonhuman Primate

  2019cites this paper
• Patterns of medication use before, during and after pregnancy in women with systemic lupus erythematosus: a population-based cohort study

  2019cites this paper
• Risk of congenital anomalies in infants born to women with autoimmune disease using biologics before or during pregnancy: a population-based cohort study.

  2019cites this paper
• Useful message in choosing optimal biological agents for patients with autoimmune arthritis.

  2019cites this paper
• Neonatal outcomes of children born to mothers on biological agents during pregnancy: state of the art and perspective.

  2019cites this paper
• The use of biologics and small molecules in pregnant patients with rheumatic diseases

  2018cites this paper
• Vaccines and Biologics

  2017cites this paper